Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @orchard_tx
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @orchard_tx
-
As investigational cell and gene therapies advance, biotech companies are working with industry stakeholders to find agreeable payment models. Orchard’s Francis Pang will join a panel at
#LSXWORLD Congress to discuss this value-based approach. Agenda here: http://bit.ly/2GcfCvP pic.twitter.com/XY0hwqaPhO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PRESS RELEASE: Orchard Therapeutics Appoints Industry Veteran Steven Altschuler, M.D. to its Board of Directors. Learn more: http://ow.ly/SyXl50ybY5G pic.twitter.com/aQNcrzr5WV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Every day, we are inspired to work alongside the rare disease community. Throughout this month we’ll be honoring
#RareDiseaseDay and the more than 300 million people worldwide living with a#raredisease. See how you can get involved:http://bit.ly/3akr6LFHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hello from 101 Seaport Boulevard! We’re excited to announce we’ve relocated our U.S. headquarters in Boston to a new office in the dynamic
#BostonSeaport district.#Orchard2020pic.twitter.com/LSaOiEg0ka
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PRESS RELEASE: Orchard Therapeutics Announces FDA Granted Orphan Drug Designation for OTL-102 for the Treatment of X-linked Chronic Granulomatous Disease (X-CGD). Learn more: http://ow.ly/Hd1E50y89OQ pic.twitter.com/kL47ECqRw9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our President of Research & Chief Scientific Officer,
@bobby_gaspar, will join today's@Endpts webinar on best practices for managing a pivotal#genetherapy trial.@JohnCendpts will moderate. Register now:http://bit.ly/2TLJUO6Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sue Rogers, Orchard’s vice president of global distribution, patient access & support services, spoke at the
@Phacilitate Leaders World 2020 event. Thank you to#PLW2020 for the opportunity to share our insights.pic.twitter.com/DtnrCpwWGl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
For children born with
#primaryimmunodeficiencies, early diagnosis is critical to improving treatment outcomes. The@ipopi_info recently released a booklet on the importance of#newbornscreening for ADA-SCID and other forms of SCID. Read the full booklet: https://bit.ly/2Rx7ueTHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, Orchard’s president and CEO, Mark Rothera, will present at the J.P. Morgan Healthcare Conference at 11:30 a.m. PST. We can’t wait to share our story, our progress and our plans for the year ahead.
#JPM20pic.twitter.com/QeQuXCCPl6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PRESS RELEASE: Orchard Therapeutics Highlights 2020 Strategic Priorities. Learn more: http://ow.ly/gL5o50xU7ZS pic.twitter.com/PCI31aINXa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our platform for our investigational therapies is based on our ex vivo autologous
#genetherapy approach which relies on the intrinsic ability of blood stem cells to self-renew in a patient’s bone marrow and potentially produce new blood cells of all types: https://bit.ly/37U6VSW pic.twitter.com/i78T9QIjEg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are part of gene therapy history – and its future. Today, we are proud to launch our new corporate branding and website that celebrates this rich history and expresses our mission to bring one-time, potentially curative GTs to people with rare diseases: https://bit.ly/2N4BBJ1 pic.twitter.com/vNJNY0GKXk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our team will start 2020 by attending the J.P. Morgan Healthcare Conference in San Francisco. We look forward to kicking off a new year of innovation and inspiration with you at
#JPM20.pic.twitter.com/bWFPbAJY1T
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PRESS RELEASE: Orchard Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference. Learn more: http://ow.ly/Q9nT50xO3yU pic.twitter.com/Y4SQny10C2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We were pleased to connect with so many of our colleagues in the hematology community at
#ASH2019. Our team was proud to host many of you at the Orchard booth and to share our exciting progress across multiple programs.pic.twitter.com/mFt5HgZmsL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As we ring in the New Year, we wish you health, happiness and limitless imagination in 2020.pic.twitter.com/aRYaPJjfmy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Manufacturing capability is key to delivering potentially life-changing gene therapies. Orchard’s CTO, Ran Zheng, recently spoke with
@LifeSciLeader1 about biopharma manufacturing trends to watch in 2020 and beyond. Read the full interview: http://ow.ly/yhQr50xFp4C pic.twitter.com/lSosSt89gV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy Holidays from our team at Orchard! Wherever you are in the world, we hope you enjoy the company of your loved ones this holiday season.
#HappyHolidaysHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re proud to support Cure MLD in their tireless efforts to help families impacted by
#MetachromaticLeukodystrophy. This global network of patient advocates and nonprofits provides families with resources, information, support.pic.twitter.com/YAMQmdV1eN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.